Outset Medical, Inc.

OM Nasdaq SEC CIK 1484612
Follow Outset Medical Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $33.6M +14.2% vs same quarter last year
Net income −$14.7M +17.7% vs same quarter last year
EPS, diluted −$0.78 +22% vs same quarter last year
Operating cash flow −$10.4M −64.2% vs same quarter last year
Revenue by quarter
$29.5M
$29.8M
$31.4M
$29.4M
$28.9M
$27.9M
$31.6M
$33.6M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income9 fiscal years
  • Revenue
  • Net income
−$200M−$100M$0$100M$200MFY17FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$119.5M−$81.7M
FY24$113.7M−$128M
FY23$130.4M−$172.8M
FY22$115.4M−$163M
FY21$102.6M−$131.9M
FY20$49.9M−$121.5M
FY19$15.1M−$68.3M
FY18$2M−$49.8M
FY17--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−3000%−2000%−1000%0%1000%FY17FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2539.1%−55.8%−68.3%
FY2433.9%−99.7%−112.6%
FY2322.2%−130.2%−132.5%
FY2215.5%−139.6%−141.2%
FY217.4%−127.2%−128.6%
FY20−26.1%−235.2%−243.3%
FY19−118.1%−466.3%−453%
FY18−304.7%−2320%−2480.3%
FY17---
Free cash flowOperating cash flow minus capital expenditure
−$200M−$150M−$100M−$50M$0FY17FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−$47.1M
FY24−$117.2M
FY23−$134.8M
FY22−$154.1M
FY21−$133.4M
FY20−$108.1M
FY19−$73.6M
FY18−$48.2M
FY17-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Outset Medical
  • Healthcare median
−3000%−2000%−1000%0%FY17FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearOutset MedicalHealthcare median
FY25−68.3%−30.8%
FY24−112.6%−47%
FY23−132.5%−58%
FY22−141.2%−80.4%
FY21−128.6%−71.9%
FY20−243.3%−62.2%
FY19−453%−46.3%
FY18−2480.3%−49.6%
FY17-−45.9%